| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1417-1423, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
F Pezzella, U Pastorino, E Tagliabue, S Andreola, G Sozzi, G Gasparini, S Menard, KC Gatter, AL Harris, S Fox, M Buyse, S Pilotti, M Pierotti and F Rilke
Department of Histopathology, University College London, UK.
Neoplastic growth is usually dependent on blood supply, and it is commonly accepted that this is provided by the formation of new vessels. However, tumors may be able to grow without neovascularization if they find a suitable vascular bed available. We have investigated the pattern of vascularization in a series of 500 primary stage I non- small-cell lung carcinomas. Immunostaining of endothelial cells has highlighted four distinct patterns of vascularization. Three patterns (which we called basal, papillary, and diffuse) have in common the destruction of normal lung and the production of newly formed vessels and stroma. The fourth pattern, which we called alveolar or putative nonangiogenic, was observed in 16% (80/500) of the cases and is characterized by lack of parenchymal destruction and absence of both tumor associated stroma and new vessels. The only vessels present were the ones in the alveolar septa, and their presence highlighted, through the whole tumor, the lung alveoli filled up by the neoplastic cells. This observation suggests that, if an appropriate vascular bed is available, a tumor can exploit it and grows without inducing neo- angiogenesis. This could have implications for strategies aimed at inhibiting tumor growth by vascular targeting or inhibition of angiogenesis.
This article has been cited by other articles:
 |
|
 |
|
  P. Sardari Nia, C. Colpaert, P. Vermeulen, J. Weyler, F. Pezzella, P. Van Schil, and E. Van Marck Different Growth Patterns of Non-Small Cell Lung Cancer Represent Distinct Biologic Subtypes Ann. Thorac. Surg., February 1, 2008; 85(2): 395 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yokoyama, G. Sedgewick, and S. Ramakrishnan Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination Cancer Res., November 15, 2007; 67(22): 10813 - 10822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dome, M. J.C. Hendrix, S. Paku, J. Tovari, and J. Timar Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications Am. J. Pathol., January 1, 2007; 170(1): 1 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Krneta, J. Kroll, F. Alves, C. Prahst, F. Sananbenesi, C. Dullin, S. Kimmina, D. J. Phillips, and H. G. Augustin Dissociation of Angiogenesis and Tumorigenesis in Follistatin- and Activin-Expressing Tumors Cancer Res., June 1, 2006; 66(11): 5686 - 5695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Renyi-Vamos, J. Tovari, J. Fillinger, J. Timar, S. Paku, I. Kenessey, G. Ostoros, L. Agocs, I. Soltesz, and B. Dome Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non-Small Cell Lung Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7344 - 7353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Herbst, A. Onn, and A. Sandler Angiogenesis and Lung Cancer: Prognostic and Therapeutic Implications J. Clin. Oncol., May 10, 2005; 23(14): 3243 - 3256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Schaefer, J. Vollmar, F. Schick, R. Vonthein, M. D. Seemann, H. Aebert, R. Dierkesmann, G. Friedel, and C. D. Claussen Solitary Pulmonary Nodules: Dynamic Contrast-enhanced MR Imaging--Perfusion Differences in Malignant and Benign Lesions Radiology, August 1, 2004; 232(2): 544 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asosingh, H. De Raeve, E. Menu, I. Van Riet, E. Van Marck, B. Van Camp, and K. Vanderkerken Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity Blood, April 15, 2004; 103(8): 3131 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Lim, A. Aggarwal, T. Agasthian, P.-S. Wong, C. Tan, E. Sim, L. Tan, P.-S. Goh, S.-C. Wang, K.-L. Khoo, et al. Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers Clin. Cancer Res., December 1, 2003; 9(16): 5980 - 5987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Holash, S. Davis, N. Papadopoulos, S. D. Croll, L. Ho, M. Russell, P. Boland, R. Leidich, D. Hylton, E. Burova, et al. VEGF-Trap: A VEGF blocker with potent antitumor effects PNAS, August 20, 2002; 99(17): 11393 - 11398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Y. T. Kao, J. L. Jenkins, K. A. Olson, M. E. Key, J. W. Fett, and R. Shapiro A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity PNAS, July 23, 2002; 99(15): 10066 - 10071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.S. Brock and S.M. Lee Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Eur. Respir. J., March 1, 2002; 19(3): 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kobayashi, K. Shirakawa, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, I. Watanabe, Y. Heike, K. Togashi, J. Konishi, et al. Rapid Accumulation and Internalization of Radiolabeled Herceptin in an Inflammatory Breast Cancer Xenograft with Vasculogenic Mimicry Predicted by the Contrast-enhanced Dynamic MRI with the Macromolecular Contrast Agent G6-(1B4M-Gd)256 Cancer Res., February 1, 2002; 62(3): 860 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Sood, M. S. Fletcher, and M. J. C. Hendrix The Embryonic-Like Properties of Aggressive Human Tumor Cells Reproductive Sciences, January 1, 2002; 9(1): 2 - 9. [Abstract] [PDF]
|
|
|
|
|
|
K. Shirakawa, H. Kobayashi, Y. Heike, S. Kawamoto, M. W. Brechbiel, F. Kasumi, T. Iwanaga, F. Konishi, M. Terada, and H. Wakasugi Hemodynamics in Vasculogenic Mimicry and Angiogenesis of Inflammatory Breast Cancer Xenograft Cancer Res., January 1, 2002; 62(2): 560 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Olson, H. R. Byers, M. E. Key, and J. W. Fett Prevention of Human Prostate Tumor Metastasis in Athymic Mice by Antisense Targeting of Human Angiogenin Clin. Cancer Res., November 1, 2001; 7(11): 3598 - 3605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takahashi, R. Kawanishi-Tabata, A. Haba, M. Tabata, Y. Haruta, H. Tsai, and B. K. Seon Association of Serum Endoglin with Metastasis in Patients with Colorectal, Breast, and Other Solid Tumors, and SuppressiveEffect of Chemotherapy on the Serum Endoglin Clin. Cancer Res., March 1, 2001; 7(3): 524 - 532. [Abstract] [Full Text]
|
|
|
|
|
|
K. Shirakawa, H. Tsuda, Y. Heike, K. Kato, R. Asada, M. Inomata, H. Sasaki, F. Kasumi, M. Yoshimoto, T. Iwanaga, et al. Absence of Endothelial Cells, Central Necrosis, and Fibrosis Are Associated with Aggressive Inflammatory Breast Cancer Cancer Res., January 1, 2001; 61(2): 445 - 451. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Herbst and I. J. Fidler Angiogenesis and Lung Cancer: Potential for Therapy Clin. Cancer Res., December 1, 2000; 6(12): 4604 - 4606. [Full Text]
|
|
|
|
|
|
A. J. Marrogi, W. D. Travis, J. A. Welsh, M. A. Khan, H. Rahim, H. Tazelaar, P. Pairolero, V. Trastek, J. Jett, N. E. Caporaso, et al. Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma Clin. Cancer Res., December 1, 2000; 6(12): 4739 - 4744. [Abstract] [Full Text]
|
|
|
|
|
|
A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K. H. Plate, and H. G. Augustin Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies Cancer Res., March 1, 2000; 60(5): 1388 - 1393. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sozzi, K. Musso, C. Ratcliffe, P. Goldstraw, M. A. Pierotti, and U. Pastorino Detection of Microsatellite Alterations in Plasma DNA of Non-Small Cell Lung Cancer Patients: A Prospect for Early Diagnosis Clin. Cancer Res., October 1, 1999; 5(10): 2689 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Holash, P. C. Maisonpierre, D. Compton, P. Boland, C. R. Alexander, D. Zagzag, G. D. Yancopoulos, and S. J. Wiegand Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF Science, June 18, 1999; 284(5422): 1994 - 1998. [Abstract] [Full Text]
|
|
|
|
|
|
J. Mattern, R. Koomagi, and M. Volm Biological Characterization of Subgroups of Squamous Cell Lung Carcinomas Clin. Cancer Res., June 1, 1999; 5(6): 1459 - 1463. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
